反応式
[O:1]1[C:6]2[CH:7]=[CH:8][CH:9]=[C:10]([CH:11]([NH2:13])[CH3:12])[C:5]=2[O:4][CH2:3][CH2:2]1.[CH3:14][NH:15][C:16]([C:18]1[CH:23]=[C:22]([O:24][C:25]2[CH:36]=[CH:35][C:28]3[N:29]=[C:30](S(C)=O)[O:31][C:27]=3[CH:26]=2)[CH:21]=[CH:20][N:19]=1)=[O:17]>C1COCC1>[CH3:14][NH:15][C:16]([C:18]1[CH:23]=[C:22]([O:24][C:25]2[CH:36]=[CH:35][C:28]3[N:29]=[C:30]([NH:13][CH:11]([C:10]4[C:5]5[O:4][CH2:3][CH2:2][O:1][C:6]=5[CH:7]=[CH:8][CH:9]=4)[CH3:12])[O:31][C:27]=3[CH:26]=2)[CH:21]=[CH:20][N:19]=1)=[O:17]参加物
4
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
To a solution of 1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-ethylamine (3 eq) in THF was added 4-(2-methanesulfinyl-benzooxazol-6-yloxy)-pyridine-2-carboxylic acid methylamide (1 eq). This was stirred at room temperature for 8 hours, concentrated and the residue was purified by preparatory reverse phase HPLC. MH+=447.1.
後処理
- concentrationconcentrated
- customthe residue was purified by preparatory reverse phase HPLC
出典と根拠
- ORDレコード
- ord-8436d1ece2474fd08d21352ee65514bf
- 出典データセット
- uspto-grants-2012_05
- 特許番号
- US08173689B2
関連ノート
読み込み中…